Impax Laboratories News

Below are the top small-cap drug manufacturers-major stocks on the NYSE, the NASDAQ and the AMEX in terms of profit margin.

HAYWARD, Calif. -- -- Impax Laboratories, Inc. held its 2012 Annual Meeting of Stockholders today in San Mateo, California.

HAYWARD, Calif. -- -- Impax Laboratories, Inc. today announced that the Company will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Wednesday, May 16, at 10:40 a.m. PT.

's stock had its "hold" rating restated by analysts at Needham & Company in a research report issued to clients and investors on Wednesday.

Endo Pharmaceuticals Holdings Inc. Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA ER And Voltaren Gel , increased 23 percent versus prior year; Driven by full quarter addition of AMS as well as Qualitest revenue growth of 8 percent.

Specialty pharmaceutical company Impax Laboratories Inc's quarterly profit beat analysts expectations as sales of its generic versions of attention deficit hyperactivity disorder drug Adderall rose nearly 50 percent.

Specialty pharmaceutical company Impax Laboratories Inc's quarterly profit beat analysts expectations as sales of its generic versions of attention deficit hyperactivity disorder drug Adderall rose nearly 50 percent.

Ireland-based drug maker Warner Chilcott PLC is back at the bargaining table, confirming Monday that it is evaluating options for its business, and is holding preliminary talks with potential buyers.